Phone: 1.510.856.5600|info@anthera.com

Press Releases

 
Press Releases
  Date Title and Summary View
Apr 20, 2005
San Francisco‚ CA – April 20‚ 2005 – Anthera Pharmaceuticals‚ Inc‚ a private start–up pharmaceutical company specializing in serious respiratory and inflammatory diseases‚ today announced it has completed its Series A Preferred financing and is moving forward under a proven leadership ...
Nov 17, 2005
San Francisco‚ CA – November 17‚ 2005 – Anthera Pharmaceuticals‚ Inc‚ a private start–up pharmaceutical company committed to addressing the unmet medical needs of patients with life–threatening inflammatory diseases‚ announced that David E. Thompson has been appointed to the Co...
Sep 6, 2006
San Francisco‚ CA – September 6‚ 2006 Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that it has entered into a license agreement with Eli Lilly and Company and Shionogi & Co., Ltd. under which Anthera has obtained worldwide (except ...
Sep 13, 2006
San Francisco‚ CA – September 13‚ 2006 – Anthera Pharmaceuticals‚ a specialty pharmaceutical company developing therapies for the treatment of serious inflammatory diseases‚ today announced it closed an initial $36 million in venture financing. The funding was co–led by VantagePoint Venture ...
Dec 10, 2006
San Mateo‚ CA – December 10‚ 2006 – After months of hard training, combined with an extraordinary personal effort to raise money for Children’s Hospital Oakland Research Institute (CHORI), Keiko Mitsunobu, Senior Director of Business Development at Anthera Pharmaceuticals, finished the Honolulu marathon...
Jan 4, 2007
San Mateo‚ CA – January 4‚ 2007 – Anthera Pharmaceuticals‚ Inc.‚ a privately held biopharmaceutical company developing anti-inflammatory drugs for chronic and acute diseases‚ announced today that the US Food and Drug Administration has approved its Investigational New Drug (IND) application ...
Jan 9, 2007
San Mateo‚ CA – January 9‚ 2007 – Anthera Pharmaceuticals‚ Inc.‚ a privately held biopharmaceutical company developing anti-inflammatory drugs‚ announced today that the U.S. Food and Drug Administration has approved its Investigational New Drug (IND) application for use of its lead compound A-0...
Feb 7, 2007
San Mateo‚ CA – February 7‚ 2007 – Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs for chronic and acute diseases, announced today that David D. Waters, MD has joined the company as Cardiovascular Research Fellow. Dr. Waters has over 20 years of exp...
Feb 13, 2007
San Mateo‚ CA – February 13‚ 2007 – Anthera Pharmaceuticals‚ Inc.‚ a privately held biopharmaceutical company developing anti–inflammatory drugs for chronic and acute diseases‚ announced today the appointment of Dr. David Waters‚ Dr. Robert Rosenson and Dr. Stephen Nicholls to its Card...
Mar 8, 2007
San Mateo‚ CA – March 8‚ 2007 – Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs for acute and chronic diseases, announced today the appointment of Drs. Alan Leff, Michael A. Matthay, B. Taylor Thompson, and Stephen Rennard to its Respiratory and Acu...
Page:
1
... NextLast
= add release to Briefcase
Print Friendly